Greatine release was compared in various conditions of muscle damage: acute myocardial infarction (AMI), unstable angina, and cardiac surgery. After AMI, serum and urine creatine concentrations increased transiently. After cardiopulmonary resuscitation, serum creatine values were significantly higher because of impaired renal function, whereas urinary creatine concentrations were comparable. In 38 patients with unstable angina, no significant changes in serum and urine creatine concentrations were seen. In 37 of 92 AMI patients, secondary creatine peaks were observed 20.9 ± 8.1 h after onset of symptoms. The magnitudes of the first and second peaks were correlated:
cardiopulmonary resuscitation, serum creatine values were significantly higher because of impaired renal function, whereas urinary creatine concentrations were comparable. In 38 patients with unstable angina, no significant changes in serum and urine creatine concentrations were seen. In 37 of 92 AMI patients, secondary creatine peaks were observed 20.9 ± 8.1 h after onset of symptoms. The magnitudes of the first and second peaks were correlated:
Spearman r = 0.66. In 24 patients who underwent cardiac surgery, the changes in creatine concentration in serum during surgery were very small, despite the presence of muscle trauma.
Indexing Terms: creatir,e kinase/cardiac enzymes /thrombolytic therapy/cardiopulmonary resuscitation
Creatine is a low-molecular-mass compound (Mr 131) abundant in both skeletal muscle and myocardial cells (1) . The availability of specific enzymatic creatine determinations made it possible to measure creatine concentrations in human body fluids in a sensitive and specific way (2) . After acute myocardial infarction (AM!), transient increases in serum and urine creatine concentrations have been observed, which has been proposed for early diagnosis of the disease (3-5 ), 5 Although losses of creatine from the infarcted zone have been observed (4) , increases in serum and urine creatine concentrations after AM! were significantly higher than the expected changes in creatine concentrations, on the basis of observed postmortem creatine losses from the infarcted zone.
As success of thrombolytic therapy largely depends on early intervention (6) , attempts have been made to introduce new biochemical markers for earlier AM! diagnosis. As rate of entrance of biochemical marker molecules into plasma greatly depends on the relative molecular mass of the compound (7), attention has been paid to low-molecular-mass markers, such as the 17-kDa protein myoglobin (present in both skeletal and heart muscle cells) (8) proteins troponin T and troponin 1 (9, 10) . The diagnostic specificity of myoglobin determinations has been questioned (8) . Despite the high organ specificity of troponin T, this indicator is positive in both AM! and unstable angina (9) .
In the present study, the relation between creatine release and clinical factors (patients' age and sex, infarct localization, and therapy) is examined.
Creatine kinetics after AMI were analyzed in patients admitted to the emergency department with complaints of typical retrostemal pain. Special attention has been paid to the value of creatine determinations in differentiating patients with AM! and those with unstable angina pectoris. As a comparative model of acute muscle tissue necrosis, creatine kinetics were also studied in a group of patients who underwent cardiac surgery.
Materials and Methods

Patients with Retrostemal Pain
A group of 134 patients admitted to the hospital with retrosternal pain suggestive of AM! were monitored during the first 24 h after admission. Patients who showed fast relief from the symptoms after administration of sublingual nitrates in the very early period (at home, during the transport to the hospital, or in the emergency room) were excluded. Among the study group, 96 patients [76 men, ages 34-81 years (62.9 ± 10.6 years, mean ± SD) and 20 women, ages 46 All analyses were done within 3 h after venipuncture.
Creatine in serum and urine was assayed with an enzymatic procedure previously described (2) on a RA-1000 analyzer (Technicon Instruments, Tarrytown, NY). Serum creatine kinase (CK; EC 2.7.3.2) activity was assayed at 37#{176}C according to Rosalki (12) ; CK isoenzyme MB (CK-MB) was assayed at 37#{176}C by an immunoprecipitation assay (13) , making use of commercial antibodies (no. 07 20658; Roche Diagnostic Systems, Nutley, NJ). Spectrophotometric readings of these enzyme activity measurements were done on a RA-1000 analyzer.
With respect to AM!, creatine values were considered positive when concentrations in serum exceeded 
Binding Analysis
Healthy human (n = 5) cardiac muscle was obtained during autopsy and the tissue extracts were prepared according to Tsung (14) . Serum samples of AM! patients (n = 5) were taken upon admission and during the phase of tardive peaks for binding analysis. In these samples, serum creatine concentrations (mean ± and male (108 ± 99 g.moIJL) AM! patients.
Secondary Creatine Maxima Figure 2 illustrates the evolution of serum creatine concentration after AM!: Two different patterns of serum creatine kinetics could be distinguished.
Next to the early rise in serum creatine concentration, additional late creatine maxima in serum were observed in 37 of 92(40%) AMI patients who survived their AM! for >12 h. These secondary creatine maxima were observed 20.9 ± 8.1 h after OOS. There were no clinical or laboratory evidences that these secondary maxima were due to reinfarction. Table 2 summarizes characteristics of infarctions in patients presenting with both types of creatine kinetics. Male/female ratio was higher (P <0.05) in patients showing monophasic release patterns. Values of secondary creatine peaks in serum correlated well with values for the early creatine maxima: y (maximum creatine of the secondary peak, moL1L) = 0.82x (maximum creatine of the first peak, moI/L) + 32.8, Spearman r = 0.66.
Binding of Creatine to Cardiac and Serum Proteins
Gel permeation chromatography of cardiac extracts revealed that the radioactivity was only found in a single peak in the terminal volume of the column, 
Creatine Kinetics in Unstable Angina
In patients with unstable angina pectoris, no significant changes of serum and urine concentration were found during the 24-h observation period. For both sexes, maximum creatine concentrations were comparable with the reference range: men, 53 ± 29 mo1IL; women, 54 ± 41 .tmoI/L (Fig. 1) 
Creatine Kinetics after Cardiac Surgery
Cardiac surgery patients were used as a control group for evaluating the effect of acute muscle damage on creatine kinetics. Table 4 summarizes data on creatine and CK during cardiac surgery for two subgroups of patients (coronary bypass and valve replacement surgery patients). Despite the presence of muscle damage and increased CKJCK-MB activities, no significant increase of creatinemia was observed (Fig. 1 ).
Discussion
After AM!, because of direct leakage of creatine from myocardial cells of the infarcted zone (3), transient increases in creatine concentration in serum and urine can be predicted. Because transit time for intracellular compounds from the infarcted zone to the plasma depends on the molecular mass of the compound, low-molecular-mass compounds such as creatine can reach the systemic circulation quickly after onset of cellular damage (7) . Because of the existence of a renal threshold for creatine, creatinuria only occurs when plasma concentrations exceed this value. In AM! patients, a sharp transient increase in crea-
i#{243}'
101 102
Time, h tine concentration in serum and urine can be observed a few hours after OOS. However, additional tardive creatine peaks observed in a large number of AM! patients cannot be explained by a direct diffusion of creatine from the infarcted zone (4) . Presence of these secondary creatine maxima after AM! could not be linked to reinfarction or differences in age or infarct localization.
Since no macromolecular binding of creatine to human plasma proteins could be demonstrated, presence of secondary peaks cannot be explained by slower diffusion rates of macromolecular bound creatme. In the thrombolyzed group, we did not observe early reinfarction, which has now become a rare phenomenon (5%) after thrombolytic therapy. In the nonthrombolyzed group, estimation of reinfarction was clearly hampered by early death (n = 4) and CPR (n = 26). Despite small differences in creatine content between anatomical regions of the heart (3), inferior infarctions show smaller creatine maxima than anterior infarctions.
After AM!, the observed plasma halflife of creatine exceeds by far the values after peroral ingestion of creatine (4).
After CPR, higher creatine maxima were found in serum. However, despite comparable values for the renal threshold in these patients, lower urine creatine values were found. As the renal threshold for creatine in these patients was comparable with the one in the Values are given for patients who survived AMI for >12 h (n = 92).
P <0.01.
Ta ble 3. Eff ects of CPR on creatine kinetics
Nonresuscitated patients (n = 70) is not possible (e.g., left bundle branch block), increased creatine concentrations could be found in serum and urine. Despite the transient character of creatine peaks in serum, which involves a risk of missing the peak when blood samples are taken too late, the bladder capacity allows detection of creatinuria as long as urine has not been passed. Upon hospital admission, sensitivity for CK/CK-MB is very low, which is consistent with earlier findings (16) .
Increased serum creatine can also originate from noncardiac causes (e.g., hyperthyreosis, skeletal muscle trauma, intramuscular injections) (1, 3) . Influence of creatine-containing diet on creatine concentrations in serum and urine is limited, as creatine is absorbed very rapidly after ingestion and the plasma half-life is short. In patients on a vegetarian diet, reference values for serum creatine are lower than in patients on a standard European diet (17) .
Since no significant correlation could be observed between the occurrence of secondary creatine peaks and the clinical situation of the patient, secondary creatine peaks in serum observed during the later phases of AM! are of limited clinical interest. Furthermore, the presence of these maxima was not related to application of thrombolytic therapy. Tardive creatine release may reflect another mechanism of creatine release. In laboratory animals, tardive creatine release patterns have been observed after total body irradiation (18 (4) . These data suggest that the triggering mechanisms causing release of creatine after AMI are different in the anesthetized cardiac surgery patient.
When comparing serum creatine and cardiac protein concentrations, one should consider that the metabolism of creatine is entirely different from the metabolism of cardiac proteins: (a) Creatine is synthesized in the liver and not in the heart (1); (b) the molecular mass of creatine is -50O times lower than the average cardiac protein; (c) creatine is actively kept in viable myocytes, due to an active pump mechanism (19) ; (d) once creatine has been released into the plasma, the skeletal muscle cells are able to take up the extracellular creatine because of an active pump system; (e) in contrast to the majority of the cardiac proteins, creatme passes the glomerulus and can be found in the glomerular filtrate.
In the kidney tubuli, there is an active reuptake process for the creatine present in the glomerular filtrate, characterized by a renal threshold value (1); and (f) creatine and creatine phosphate are spontaneously metabolized into creatinine at a constant rate.
In conclusion, creatine release was compared in various conditions of muscle damage: AM!, unstable angina, and cardiac surgery.
After AM!, serum and urine creatine concentrations increased transiently. In unstable angina, no significant changes in serum and urine creatine concentrations were seen. In cardiac surgery, the changes in creatine concentration in serum during surgery were small, despite the presence of muscle trauma. Further studies are therefore needed to unravel the triggering mechanisms of creatine after different types of muscle damage.
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